Treatment Pattern of Heart Failure Patients in Sweden During 2021–2023 in Relation to Updated Treatment Recommendations
Even though the implementation of the treatment recommendations for HF is not yet optimal, this study found a notable adoption of quadruple therapy in Sweden. There was an increased use of SGLT2 inhibitors and quadruple therapy, beginning even before the introduction of the updated Swedish treatment recommendations.
Authors
- Staffan Gustavsson
- Magnus Husberg (ORCID: https://orcid.org/0000-0002-3057-8933)
- Mattias Enoksson
- Lars‐Åke Levin (ORCID: https://orcid.org/0000-0003-2581-4863)
- Lars Bernfort (ORCID: https://orcid.org/0000-0003-0537-3319)
- Michaela Eklund (ORCID: https://orcid.org/0009-0007-7931-8941)
- Thérèse Eriksson (ORCID: https://orcid.org/0000-0001-6855-6169)
Institutions
- Linköping University (SE)
- Boehringer Ingelheim (Sweden) (SE)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1007/s40801-025-00494-x
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Region Östergötland